Navigation Links
Testing for hereditary breast cancer? Toolkit helps families talk, cope, decide what to do
Date:9/11/2013

ANN ARBORActress Angelina Jolie made headlines in May when she revealed she underwent a preventive double mastectomy to reduce her risk of cancer.

According to the New York Times, Jolie carried a genetic mutation in the BRCA1 gene, which elevated her chances of breast and ovarian cancer to 87 percent and 50 percent, respectively. She also has opted to have her ovaries removed.

Discussing the genetic mutation in the family can be very difficult. To that end, Maria Katapodi, associate professor at the University of Michigan School of Nursing, developed the Family Gene Toolkit to help families communicate about the mutation, elevated cancer risk and the importance of genetic testing.

By involving entire families, the kit aims to take the burden of disclosure and explaining complex genetic information away from the mutation carrier, Katapodi said. The hope is that these discussions occur soon after a mutation is detected in one family member and before other members develop cancer.

"Our goal is to help families have open communication, cope and make better decisions when someone learns they are a carrier of a cancer gene mutation," she said.

Jolie's story renewed the debate over genetic testing and pre-emptive surgery when a BRCA1 or BRCA2 mutation is present. Several of her family members, including her mother and aunt, died of ovarian or breast cancer. Jolie's aunt, who carried the mutation but didn't know it, died just weeks after Jolie's announcement.

"Cancers caused by these genes may be more aggressive and affect younger people, so they take away more years of life, Katapodi said. "If you know you have a high chance of getting cancer, you can consider issues like fertility and family planning, career and life goals before you make a decision on treatment.

"You can really look at the big picture. You're not just someone with a genetic mutation. You're a person with feelings, a woman, a mother,
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Food Safety Products Market And Food Safety Testing Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2010 - 2018
2. GlobalSurance Conducts Survey of Major Insurers on Breast Cancer Testing Policies
3. European Food Safety Testing Market Worth $4,068.8 Million By 2018 - New Report by MarketsandMarkets
4. Rehab Management Solutions Offers 2-Day Educational Training to Physical & Occupational Therapists on Functional Testing
5. ANY LAB TEST NOW® Launches New Pre-Testosterone Replacement Therapy and Continued Testosterone Replacement Therapy Lab Testing Panels
6. Neurocognitive testing more accurate than self-reporting of cheerleaders concussion recovery
7. Natus Launches New Website for Paternity DNA Testing in the New Jersey Area
8. Genetic Testing for Kidney Disease Among African-Americans with Hypertension to Become Part of Primary Care Offerings Through Mount Sinai and Partners
9. Mount Sinai launches first-ever genetic testing program in the primary care setting
10. North America Food Safety Testing Market to Reach $5,460.1 Million by 2018 at a CAGR of 7.3% - New Report by MarketsandMarkets
11. The Texas Thyroid Institute is Now Testing for Food Sensitivities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Catalent Pharma Solutions, the ... development solutions for drugs, biologics and consumer health ... Clinical Supply Services, and Chris Greco, Manager, Comparator ... Strategies for Active Control Clinical Trials” at the ... place on the 9th – 10th September, 2014 ...
(Date:8/28/2014)... nasal septum cells. Researchers at the University and the ... the nasal septum are able to adapt to the ... articular cartilage defects. The nasal cartilage cells, ability to ... with the expression of so-called HOX genes. The scientific ... research results together with the report of the first ...
(Date:8/28/2014)... and over who identify themselves as ,old, feel worse ... they have lower value than younger age groups. , ... titled ,Being old and ill, across different countries: social ... data from the European Social Survey. Respondents, who were ... their health., The researchers found that those living in ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 BCC Research ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the ... $419.7 million in 2013. Driven by the need for ... medical tourism in emerging geographies, the market is expected ... growth rate (CAGR) of 8.5% from 2013 through 2018. ...
(Date:8/28/2014)... 2014 AmeriPride Services, a leading textile ... the launch of its new Customer Portal, an online ... and more convenient for customers. The industry-leading digital tool ... communicate with the company. , Features of the new ... Access, download and pay bills online , ...
Breaking Medicine News(10 mins):Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... on Monday, August 11, 2008 at 8:30am ... ... Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on the,acquisition, development ... including renal disease and cancer, today announced its results,for the second quarter ...
... Aug. 8 "The passage of federal,legislation two years ... by Congress to the alarming surge in childhood obesity ... for the school wellness movement,",says a 60-page report issued ... "That legislation has gotten the ball rolling by,identifying schools ...
... Inc., administrator for the,HealthShares(TM) Indexes, a series ... Traded Funds, today announced the following changes,effective ... August 11, 2008: Enzo Biochem,Inc. will replace ... the,HealthShares(TM) Infectious Disease Index and the HealthShares(TM),Composite ...
... mothers milk makes for even-keeled kids, , , FRIDAY, Aug. ... benefits to both mother and baby, including a stronger ... for mom. There are even some known psychological benefits ... But British researchers have recently discovered another mental bonus ...
... MedQuist,Inc.,(Nasdaq: MEDQ ) the largest Medical Transcription ... for the quarter ended June,30, 2008. Revenue for the ... million in the second quarter of 2007. The decrease ... year period was primarily due to,customer losses experienced during ...
... variation , , FRIDAY, Aug. 8 (HealthDay News) -- A British ... intake and high blood pressure. , The study, which included ... genetic factor that might make people more or less vulnerable ... variants of a gene for angiotensinogen, a molecule that can ...
Cached Medicine News:Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 2Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 3Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 4Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 5Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 2Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 3Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 4Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Infectious Disease and HealthShares(TM) Composite Indexes 2Health News:Breast-Feeding: The Stress Buster That Lasts for Years 2Health News:Breast-Feeding: The Stress Buster That Lasts for Years 3Health News:MedQuist Reports Second Quarter 2008 Results 2Health News:MedQuist Reports Second Quarter 2008 Results 3Health News:MedQuist Reports Second Quarter 2008 Results 4Health News:MedQuist Reports Second Quarter 2008 Results 5Health News:MedQuist Reports Second Quarter 2008 Results 6Health News:MedQuist Reports Second Quarter 2008 Results 7Health News:MedQuist Reports Second Quarter 2008 Results 8Health News:MedQuist Reports Second Quarter 2008 Results 9Health News:Too Much Salt Boosts Blood Pressure 2
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), an ... FDA clearance for and commercializing its CE Marked ... in identifying children, adolescent, and young adult patients in ... appendicitis, today announced it will present at three upcoming ... Annual Global Investment Conference being held in ...
(Date:8/28/2014)... 2014 Telik, Inc. (OTCQB: TELK), a ... with MabVax Therapeutics, Inc. on July 8, 2014, ... to the development of its lead antibody program ... the Company,s internally developed antibody discovery platform.  These ... antibody based therapeutic and diagnostic products based on ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
... traits contribute to risk, of skin cancer; findings will ... May 18 In two papers published,today, deCODE scientists ... the company,s recent findings in the genetics of pigmentation,traits ... of these,common variants also confer risk of two types ...
... Annual Meeting Will Further Demonstrate, the Strength ... CAMBRIDGE, Mass., May 16 Millennium Pharmaceuticals,The Takeda Oncology ... are scheduled to be featured at the 2008 American ... May 30 -,June 3, 2008. The data will highlight ...
Cached Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8
... Ad-Techs Foramen Ovale Electrodes provide you ... These electrodes offer the same proven design ... that they are placed using an introducing ... a smaller electrode body diameter, 3 to ...
... The Small Joint Ball Electrode is ... small joint applications. With its 2 ... controlled capsuloligamentous or tendinous tissue coagulation ... used in conjunction with the OPES ...
... designed to replace the carpal scaphoid bone. The ... which fits under a shelf formed in the ... hole on the proximal hole for suture fixation. ... early postoperative period until a firm capsuloligamentous system ...
... Kompressor is a two-piece Titanium (Ti-6Al-4V) ... Mini) and a variety of lengths. The ... screw and sterile packaged. A single instrument ... or removal of both Standard and Mini ...
Medicine Products: